HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matrine Inhibits CNS Autoimmunity Through an IFN-β-Dependent Mechanism.

Abstract
Matrine (MAT), a quinolizidine alkaloid component derived from the root of Sophora flavescens, suppresses experimental autoimmune encephalomyelitis (EAE), the animal model of multiple sclerosis (MS), by inducing the production of immunomodulatory molecules, e.g., IL-10. In an effort to find the upstream pathway(s) of the mechanism underlying these effects, we have tested certain upregulated immunomodulatory molecules. Among them, we found increased levels of IL-27 and IFN-β, one of the first-line MS therapies. Indeed, while low levels of IFN-β production in sera and type I interferon receptor (IFNAR1) expression in spinal cord of saline-treated control EAE mice were detected, they were significantly increased after MAT treatment. Increased numbers of CD11b+IFN-β+ microglia/infiltrating macrophages were observed in the CNS of MAT-treated mice. The key role of IFN-β induction in the suppressive effect of MAT on EAE was further verified by administration of anti-IFN-β neutralizing antibody, which largely reversed the therapeutic effect of MAT. Further, we found that, while MAT treatment induced production of IL-27 and IL-10 by CNS microglia/macrophages, this effect was significantly reduced by IFN-β neutralizing antibody. Finally, the role of IFN-β in MAT-induced IL-27 and IL-10 production was further confirmed in human monocytes in vitro. Together, our study demonstrates that MAT exerts its therapeutic effect in EAE through an IFN-β/IL-27/IL-10 pathway, and is likely a novel, safe, low-cost, and effective therapy as an alternative to exogenous IFN-β for MS.
AuthorsYao-Juan Chu, Wen-Di Ma, Rodolfo Thome, Jie-Dan Ping, Fang-Zhou Liu, Meng-Ru Wang, Ming-Liang Zhang, Guangxian Zhang, Lin Zhu
JournalFrontiers in immunology (Front Immunol) Vol. 11 Pg. 569530 ( 2020) ISSN: 1664-3224 [Electronic] Switzerland
PMID33101289 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2020 Chu, Ma, Thome, Ping, Liu, Wang, Zhang, Zhang and Zhu.
Chemical References
  • Alkaloids
  • Antibodies, Monoclonal
  • Antibodies, Neutralizing
  • Cytokines
  • Quinolizines
  • Interferon-beta
  • Matrines
Topics
  • Alkaloids (pharmacology)
  • Animals
  • Antibodies, Monoclonal (pharmacology)
  • Antibodies, Neutralizing (pharmacology)
  • Autoimmunity (drug effects)
  • Central Nervous System (drug effects, immunology, metabolism)
  • Cytokines (metabolism)
  • Disease Models, Animal
  • Disease Susceptibility
  • Encephalomyelitis, Autoimmune, Experimental
  • Female
  • Fluorescent Antibody Technique
  • Humans
  • Interferon-beta (antagonists & inhibitors, metabolism)
  • Mice
  • Monocytes (drug effects, immunology, metabolism)
  • Multiple Sclerosis (diagnosis, drug therapy, etiology, metabolism)
  • Quinolizines (pharmacology)
  • Severity of Illness Index
  • Matrines

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: